KCNK5 and rheumatoid arthritis: The previous implication of this gene in RA disease progression, as well as the specific observation that increases in KCNK5 expression are correlated with the failure of antibody-based therapies targeting similar inflammatory pathways involved in RA disease pathology, may suggest that additional investigation of KCNK5 as a modifier of RA therapies is merited.